Subject Matter Eligibility for Biotechnology Patents in the United States

Bloomberg BNA’s Life Sciences Law & Industry Report
September 29, 2017

Steptoe’s Ying Li and Siew Chong co-authored an article titled “Subject Matter Eligibility for Biotechnology Patents in the United States” for Bloomberg BNA’s Life Sciences Law & Industry Report. The article, published September 29, provides an overview on the current legal landscape on this issue with respect to biotechnology patents, especially in the field of personalized medicine.